Navigation Links
Two Mount Sinai Physicians Elected To The Institute Of Medicine
Date:10/24/2013

rney expressed gratitude to both Dr. Meier and Dr. Sklar for their contributions. "We are very proud of Dr. Meier, who is a model educator, researcher, physician and human being. She has improved outcomes and enhanced quality of life for patients, survivors and their families, at The Mount Sinai Medical Center and globally," said Dr. Charney. "I also congratulate Dr. Pamela Sklar for this outstanding honor from the Institute of Medicine," said Dr. Charney. "Her research has greatly enhanced our understanding of the role of genetic variants in mental illnesses, and supports Mount Sinai’s commitment to precision medicine, by developing therapies tailored to individual patient needs through the application of genomic information.”

“I am tremendously honored to be invited to join the Institute of Medicine,” said Dr. Meier. Under Dr. Meier’s leadership, the number of palliative care programs in US hospitals has more than tripled in the last 10 years. Dr. Meier served as founding director of the Lilian and Benjamin Hertzberg Palliative Care Institute at Mount Sinai from 1997-2011. She is currently Principal Investigator on a National Cancer Institute-funded five-year multisite study on the outcomes of hospital palliative care services in cancer patients. Dr. Meier is the recipient of numerous awards, including a 2008 MacArthur Fellowship for individuals who have shown exceptional creativity in their work and the promise to do more.

“The election is an honor, and I hope to contribute to the IOM on issues regarding the role of genetics in personalized medicine, ethical questions surrounding genetic testing for psychiatric diseases and translating research findings into clinical practice,” said Dr. Sklar. Dr. Sklar has an extraordinary track record of leadership in collaborative research settings, including the Psychiatric Genomics Consortium. Her research focuses on DNA and RNA variation, rare and common, trailblazing with stud
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New Research from Mount Sinai on Alcohol Could Spur Development of Antidote
2. Mount Sinai finds value and limitations of patient assistance programs for women with breast cancer
3. Mount Sinai Researchers Find Value -- and Limitations -- of Patient Assistance Programs for Women with Breast Cancer
4. Mount Sinai Queens Breaks Ground for Expansion Project
5. Invisalign Dentist, Grant Road Dental, to Host Invisalign Day in Mountain View, CA. on October 1, 2013
6. Head Mounted Display (HMD, Helmet Mounted Display, Head Mounted Display/Computing) Market (2012 - 2017) – New Report by MarketsandMarkets
7. Wright Conserve Hip Replacement Lawsuits Continue to Mount in Federal Litigation, Bernstein Liebhard LLP Reports
8. Avenidas to Host 10th Annual Caregiver Conference in Mountain View, CA
9. NIH Grant to support Mount Sinai Research Program to Create Biological Network Model of Alzheimer’s Disease in partnership with New York Stem Cell Foundation
10. Stryker Hip Lawsuits Continue to Mount as Claims in New Jersey Stryker Hip Recall Litigation Approach 400, Bernstein Liebhard LLP Reports
11. Fully Dissolvable, Temporary Stent for Opening Heart Artery Blockages Now Being Tested at The Mount Sinai Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 29, 2015 , ... ... localized area with stretching, soft tissue manipulation. Platelet rich plasma injections also have ... through research to improve treatment outcomes. This localized treatment seems to address ...
(Date:8/28/2015)... Madre, CA (PRWEB) , ... August 28, 2015 ... ... solutions to wound center management, Decatur County Memorial Hospital recently transitioned management companies ... model of Wound Center Management for their outpatient wound center. , Transitioning ...
(Date:8/28/2015)... CA (PRWEB) , ... August 28, 2015 , ... An ... journey that local pizza maker Paul LaRocco has gone through to open a pizzeria ... approval and permitting process tends to take several months, but the current process, having ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a non-invasive ... two years, the longest of any cellulite reduction system currently on the market. ... solution for their cellulite, according to Dr. Robert Weiss, director of the premier MD ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... 20 grams of high grade protein with zero fat, carbs, sugar, gluten, lactose ... been named a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , ...
Breaking Medicine News(10 mins):Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3
... SALT LAKE CITY, April 17 Dynatronics,Corporation (Nasdaq: ... two new,products: the DynaPro Spinal Health System for ... oscillation therapy unit., "The new DynaPro Spinal ... benefits of decompression with light therapy,core-stabilization exercises and ...
... Blue Shield of,Minnesota (Blue Cross) today released its financial ... of 0.3 percent ($25.1 million) on,full-year revenues of $8.4 ... offset $104 million in operating losses. Blue,Cross remains financially ... claims and operating expenses., More than 90 cents ...
... Heavy drinkers and heavy,smokers develop Alzheimer,s disease years ... or smoke heavily, according to research that,will be ... Anniversary,Annual Meeting in Chicago, April 12-19, 2008., ... if we can,reduce or eliminate heavy smoking and ...
... Susser, MD, DrPH, Anna Cheskis Gelman and Murray Charles ... at the Mailman School of Public Health and professor ... the 2008 Distinguished Investigator Award from NARSAD, the world,s ... Dr. Susser was selected for a study on famine ...
... The National,Association of Specialty Health Organizations (NASHO) ... Award. The recipient of the award,will be ... programs and practices., (Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU004LOGO ... the specialty health industry, we felt it ...
... April 17 Seven children,from across the United ... nerve rerouting surgery for patients,with spina bifida. The ... Royal Oak, Mich., The children previously required ... or endured significant incontinence. But as a result ...
Cached Medicine News:Health News:Dynatronics Introduces New DynaPro Spinal Health System and X5 'Turbo' 2Health News:Blue Cross and Blue Shield of Minnesota Releases 2007 Financial Results 2Health News:Alzheimer's Starts Earlier for Heavy Drinkers, Smokers 2Health News:Ezra Susser, MD, DrPH, receives Distinguished Investigator Award from NARSAD 2Health News:The National Association of Specialty Health Organizations to Recognize Excellence in Technology Education With Industry Award 2Health News:Beaumont Sees Results in Nation's 1st Urinary Nerve Rewiring Surgeries for Spina Bifida Patients 2Health News:Beaumont Sees Results in Nation's 1st Urinary Nerve Rewiring Surgeries for Spina Bifida Patients 3
(Date:8/28/2015)... JACKSONVILLE, Fla. , Aug. 28, 2015  With ... reaching deadlier heights, Jacksonville ... Philip Hemphill is helping to explain why ... Fentanyl is approximately 40 to 50 times more potent ... by recreational users as heroin, the risk of death ...
(Date:8/28/2015)... , Aug. 28, 2015  CytomX Therapeutics, Inc., a ... cancer, today announced the filing of a registration statement ... Commission (SEC) relating to a proposed initial public offering ... be offered and the price range for the offering ... its common stock under the symbol "CTMX" on the ...
(Date:8/28/2015)... 28, 2015 Research ... addition of the "Investigation Report on China,s ... Originally discovered by Welfide (Mitsubishi Tanabe ... Ltd) as an inflammatory drug, pranoprofen was later ... Ltd under the trade name of pranopulin for ...
Breaking Medicine Technology:Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Pranoprofen Market, 2010-2019 2
... Calif., Feb. 28, 2011 Varian Medical Systems, Inc. (NYSE: ... into a new agreement with Bank of America N.A. to ... share repurchase program.   Under the accelerated repurchase ... N.A. and receive approximately 3.5 million shares, or 85% of ...
... 2011 S*BIO Pte Ltd today announced that its ... (PK/PD) properties leading to significant anti-tumor efficacy in rapamycin-sensitive ... in vitro data on SB2343 were presented ... on Targeting PI3K/mTOR Signaling in Cancer held in San ...
Cached Medicine Technology:Varian Medical Systems Announces New $280 Million Accelerated Stock Repurchase 2Varian Medical Systems Announces New $280 Million Accelerated Stock Repurchase 3S*BIO's Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models 2S*BIO's Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models 3
... x 7.5 x 80 mm. Storz ... line designed by Harvey A. Lincoff, ... closed cell sponge which is non-toxic ... rounded edges to minimize scleral intrusion. ...
... 7.5 x 80 mm. Storz offers ... designed by Harvey A. Lincoff, M.D. ... cell sponge which is non-toxic and ... edges to minimize scleral intrusion. These ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
... Size: 5.0 x 2.5 x 80 mm. Half ... by Harvey A. Lincoff, M.D. has been modified ... design. The material is a closed cell sponge ... with rounded edges to minimize scleral intrusion. These ...
Medicine Products: